
ApoA-I Milano: A variant of apolipoprotein A-I identified in about 40 inhabitants of Limone sul Garde, a small town in rural North Italy, who had extraordinarily low HDL levels, levels so low that they were off the scale. Because HDL is the "good" <a href="https://www.medicinenet.com/cholesterol_management/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">cholesterol</a>, it was expected that these people would have very high rates of <a href="https://www.medicinenet.com/heart_disease_coronary_artery_disease/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">heart disease</a>. Instead, they seemed to be protected from heart disease and to enjoy longer lives than usual. The infusion of recombinant ApoA-I Milano-phospholipid complexes reportedly produces rapid regression of coronary artery atherosclerosis.